Sickle Cell Disease (SCD)

Sickle Cell Disease (SCD) research and management focus on this inherited blood disorder characterized by abnormal hemoglobin. Recent advancements include disease-modifying therapies, gene editing trials, and improved pain management techniques. The field strives to enhance the quality of life for SCD patients by reducing complications, minimizing pain crises, and preventing organ damage. Additionally, prenatal testing and counseling aid in early diagnosis and family planning. SCD research is committed to finding curative solutions and alleviating the impact of this condition on affected individuals and their families.

  • SCD treatments and complications.
  • Advances in SCD research.
  • Strategies for improving SCD care.

    Related Conference of Sickle Cell Disease (SCD)

    November 13-14, 2025

    21st Global Summit on Hematology and Blood Disorders

    Aix-en-Provence, France
    May 28-29, 2026

    5th European Congress on Hematology

    Madrid, Spain
    August 10-11, 2026

    24th World Hematology Congress

    Berlin, Germany

    Sickle Cell Disease (SCD) Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in